Literature DB >> 770362

The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment.

J Gerlach, K Thorsen.   

Abstract

24 hospitalized psychiatric patients with neuroleptic-induced tardive dyskinesia were treated with alpha-methyl-para-tyrosine (AMPT), 4 g daily for 3 days, and biperiden, 12 mg daily for 3 weeks. The results were evaluated blindly by means of videotape technique. The frequency of tardive dyskinesia was significantly reduced by AMPT and significantly increased by biperiden. The amplitude was reduced by AMPT in ten cases, unchanged in 12 cases and increased in two cases. Biperiden significantly increased the amplitude. The duration of each separate tongue protrusion and/or mouth opening was significantly increased by AMPT and reduced or unchanged by biperiden. It is concluded that a reduced dopaminergic activity (pharmacological or organic) may constitute the primary pathogenetic background for tardive dyskinesia, but that dopaminergic hypersensitivity and/or cholinergic hypofunction is necessary before the hyperkinetic element of the movement disturbances can minifest itself.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 770362     DOI: 10.1159/000468206

Source DB:  PubMed          Journal:  Int Pharmacopsychiatry        ISSN: 0020-8272


  16 in total

1.  Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.

Authors:  J Gerlach; H Simmelsgaard
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

2.  The management of neuroleptic-induced CNS effects.

Authors:  B F Hoffman; M V Seeman
Journal:  Can Fam Physician       Date:  1981-10       Impact factor: 3.275

3.  Relationship between tardive dyskinesia, L-Dopa-induced hyperkinesia and parkinsonism.

Authors:  J Gerlach
Journal:  Psychopharmacology (Berl)       Date:  1977-03-16       Impact factor: 4.530

Review 4.  Assessment of extrapyramidal disorders.

Authors:  C D Marsden; M Schachter
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

Review 5.  Antipsychotic drug treatment for elderly people with late-onset schizophrenia.

Authors:  Adib Essali; Ghassan Ali
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

6.  Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenithixol) in rats.

Authors:  E B Nielsen; M Lyon
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

7.  Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia.

Authors:  Julie Eve Desmarais; Linda Beauclair; Lawrence Annable; Marie-Claire Bélanger; Theodore T Kolivakis; Howard C Margolese
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

8.  Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.

Authors: 
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

9.  Long-term behavioural and biochemical effects following prolonged treatment with a neuroleptic drug (flupenthixol) in rats.

Authors:  E B Nielsen
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

10.  Effect of baclofen on tardive dyskinesia.

Authors:  J Gerlach; T Rye; P Kristjansen
Journal:  Psychopharmacology (Berl)       Date:  1978-03-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.